Found: 37
Select item for more details and to access through your institution.
A Unique Case of Combined Nodular and Tracheobronchial Amyloidosis.
- Published in:
- Oxford Medical Case Reports, 2021, v. 2021, n. 2, p. 1, doi. 10.1093/omcr/omaa134
- By:
- Publication type:
- Article
Disparities in time to treatment with oral antimyeloma medications.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01128-1
- By:
- Publication type:
- Article
Effects of early palliative care integration on patients with newly diagnosed multiple myeloma.
- Published in:
- Supportive Care in Cancer, 2024, v. 32, n. 7, p. 1, doi. 10.1007/s00520-024-08665-2
- By:
- Publication type:
- Article
External validation of the SAVED score for venous thromboembolism risk stratification in patients with multiple myeloma receiving immunomodulatory drugs.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 2, p. 280, doi. 10.1111/bjh.18630
- By:
- Publication type:
- Article
Validation of the IMPEDE VTE score for prediction of venous thromboembolism in multiple myeloma: a retrospective cohort study.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 6, p. 1213, doi. 10.1111/bjh.17505
- By:
- Publication type:
- Article
Characterisation and prognostic impact of immunoparesis in relapsed multiple myeloma.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 6, p. 1074, doi. 10.1111/bjh.16488
- By:
- Publication type:
- Article
Real‐world data on safety and efficacy of venetoclax‐based regimens in relapsed/refractory t(11;14) multiple myeloma.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 6, p. 1136, doi. 10.1111/bjh.16454
- By:
- Publication type:
- Article
Daratumumab proves safe and highly effective in AL amyloidosis.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 2, p. 342, doi. 10.1111/bjh.15455
- By:
- Publication type:
- Article
Daratumumab monotherapy for relapsed POEMS syndrome.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. E291, doi. 10.1002/ajh.27050
- By:
- Publication type:
- Article
Health‐related quality of life in patients with light chain amyloidosis treated with bortezomib, cyclophosphamide, and dexamethasone ± daratumumab: Results from the ANDROMEDA study.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 6, p. 719, doi. 10.1002/ajh.26536
- By:
- Publication type:
- Article
Pomalidomide-based maintenance post-autologous hematopoietic cell transplantation in multiple myeloma: a case series.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Management of Relapsed–Refractory Multiple Myeloma in the Era of Advanced Therapies: Evidence-Based Recommendations for Routine Clinical Practice.
- Published in:
- Cancers, 2023, v. 15, n. 7, p. 2160, doi. 10.3390/cancers15072160
- By:
- Publication type:
- Article
Emerging Advances in the Management of Cardiac Amyloidosis.
- Published in:
- Current Cardiology Reports, 2015, v. 17, n. 11, p. 1, doi. 10.1007/s11886-015-0653-1
- By:
- Publication type:
- Article
Evaluating the effects of lenalidomide induction therapy on peripheral stem cells collection in patients undergoing autologous stem cell transplant for multiple myeloma.
- Published in:
- Supportive Care in Cancer, 2013, v. 21, n. 9, p. 2437, doi. 10.1007/s00520-013-1808-5
- By:
- Publication type:
- Article
Precursor T Cell Acute Lymphoblastic Lymphoma Presenting as Bilateral Facial Nerve Palsy.
- Published in:
- Chemotherapy (0009-3157), 2010, v. 56, n. 3, p. 258, doi. 10.1159/000316847
- By:
- Publication type:
- Article
Assessment and monitoring of patients receiving chemotherapy for multiple myeloma: strategies to improve outcomes.
- Published in:
- Blood & Lymphatic Cancer: Targets & Therapy, 2016, v. 6, p. 21, doi. 10.2147/BLCTT.S90764
- By:
- Publication type:
- Article
Clinical Efficacy of Retreatment With Venetoclax-Based Therapy in Relapsed-Refractory t(11;14) Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 11, p. 857, doi. 10.1016/j.clml.2023.07.007
- By:
- Publication type:
- Article
NS-62: The Importance of regular disease monitoring for patients with low or low intermediate risk Monoclonal Gammopathy of Undetermined Significance (MGUS).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S166, doi. 10.1016/S2152-2650(21)02356-9
- By:
- Publication type:
- Article
Daratumumab-based Regimen in Treating Clonal Plasma Cell Neoplasms in Solid Organ Transplant Recipients.
- Published in:
- 2020
- By:
- Publication type:
- Case Study
Ibrutinib is Effective in Refractory Type II Cryoglobulinemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
An Advanced Practice Provider-led, Outpatient Consult Clinic for Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) and Plasma Cell Disorders (PCDs): The Cleveland Clinic Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e342, doi. 10.1016/j.clml.2019.09.565
- By:
- Publication type:
- Article
Lenalidomide-Related Diarrhea Correlates with Disease Control in Newly-Diagnosed Patients with Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e341, doi. 10.1016/j.clml.2019.09.563
- By:
- Publication type:
- Article
A Phase 1/2 Trial of Low-Dose Continuous Azacitidine in Combination with Lenalidomide and Low-Dose Dexamethasone in Relapsed/Refractory Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e262, doi. 10.1016/j.clml.2019.09.434
- By:
- Publication type:
- Article
Real World Data on the Safety and Efficacy of Pomalidomide as a Single Agent and in Combination with Corticosteroids in Relapsed and Refractory Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e240, doi. 10.1016/j.clml.2019.09.399
- By:
- Publication type:
- Article
Future of Personalized Therapy Targeting Aberrant Signaling Pathways in Multiple Myeloma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Arterial thromboembolism in multiple myeloma in the context of modern anti-myeloma therapy.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41408-020-00397-w
- By:
- Publication type:
- Article
Investigational Monoclonal Antibodies in the Treatment of Multiple Myeloma: A Systematic Review of Agents under Clinical Development.
- Published in:
- Antibodies (2073-4468), 2019, v. 8, n. 2, p. 34, doi. 10.3390/antib8020034
- By:
- Publication type:
- Article
Solitary extramedullary plasmacytoma of the penis.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
Outcomes of therapeutic plasma exchange for the treatment of patients with multiple myeloma cast nephropathy.
- Published in:
- Hematological Oncology, 2024, v. 42, n. 4, p. 1, doi. 10.1002/hon.3293
- By:
- Publication type:
- Article
Final analysis of a phase 1/2b study of ibrutinib combined with carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Progression with clinical features is associated with worse subsequent survival in multiple myeloma.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 4, p. 439, doi. 10.1002/ajh.25415
- By:
- Publication type:
- Article
Supra-normal left ventricular ejection fraction in cardiac amyloidosis.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Myonecrosis in Sickle Cell Anemia--Overlooked and Underdiagnosed.
- Published in:
- 2010
- By:
- Publication type:
- Case Study
Utility of Bruton's Tyrosine Kinase Inhibitors in Light Chain Amyloidosis Caused by Lymphoplasmacytic Lymphoma (Waldenström's Macroglobulinemia).
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Current Novel Targeted Therapeutic Strategies in Multiple Myeloma.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 11, p. 6192, doi. 10.3390/ijms25116192
- By:
- Publication type:
- Article
Neuropathy and efficacy of once weekly subcutaneous bortezomib in multiple myeloma and light chain (AL) amyloidosis.
- Published in:
- PLoS ONE, 2017, v. 12, n. 3, p. 1, doi. 10.1371/journal.pone.0172996
- By:
- Publication type:
- Article